Pharma can start rebuilding credibility by developing a thorough, organized campaign that cuts across all disease categories and the industry as a whole.
Just two short decades ago, pharmaceutical communications were largely limited to scientific publications, detailing and advertising to physicians, and cranking out annual reports for investors.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva